Searching News Database: Vagus Nerve Stimulation
HSMN NewsFeed - 31 Aug 2021
MicroTransponder(R) Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors
MicroTransponder(R) Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors
HSMN NewsFeed - 12 May 2015
Sorin And Cyberonics Announce Executive Leadership Team For The New Company Upon Close Of Merger
Sorin And Cyberonics Announce Executive Leadership Team For The New Company Upon Close Of Merger
HSMN NewsFeed - 9 Oct 2013
electroCore Signs $14 Million Deal with waveCore to Develop Wireless Vagus Nerve Stimulation Technology
electroCore Signs $14 Million Deal with waveCore to Develop Wireless Vagus Nerve Stimulation Technology
HSMN NewsFeed - 9 Jan 2013
Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies
Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies
HSMN NewsFeed - 7 Jun 2012
Neurotech s.a. Announces European CE Mark Approval for the ADNS-300 System to Treat Refractory Epilepsy
Neurotech s.a. Announces European CE Mark Approval for the ADNS-300 System to Treat Refractory Epilepsy
HSMN NewsFeed - 2 Apr 2012
UCLA Neurologist and Innovator of Trigeminal Nerve Stimulation Joins NeuroSigma
UCLA Neurologist and Innovator of Trigeminal Nerve Stimulation Joins NeuroSigma
HSMN NewsFeed - 14 Jun 2011
CerebralRx Enters Global Neuromodulation Market With the FitNeS(TM) System for Treating Epilepsy
CerebralRx Enters Global Neuromodulation Market With the FitNeS(TM) System for Treating Epilepsy
HSMN NewsFeed - 26 Apr 2011
BioControl Medical Launches the INOVATE-HF IDE Study of Its CardioFit(R) System for Heart Failure
BioControl Medical Launches the INOVATE-HF IDE Study of Its CardioFit(R) System for Heart Failure
HSMN NewsFeed - 1 Feb 2011
Cyberonics Announces FDA Approval of Aspire High Capacity Generator for VNS Therapy
Cyberonics Announces FDA Approval of Aspire High Capacity Generator for VNS Therapy
HSMN NewsFeed - 20 Aug 2007
New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
HSMN NewsFeed - 1 May 2007
Daniel J. Moore Appointed President and Chief Executive Officer of Cyberonics
Daniel J. Moore Appointed President and Chief Executive Officer of Cyberonics
Additional items found! 48
Members Archive contains
48 additional stories matching:
Vagus Nerve Stimulation
(Password required)
Vagus Nerve Stimulation
(Password required)